Cash & equivalents decreased 36.2%
Cash & equivalents changed -36.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -36.2% from the comparable as-filed period.
Net income changed +556.8% from the comparable as-filed period.
Operating income changed +162.1% from the comparable as-filed period.
Operating margin changed +944 basis points from the comparable as-filed period.
Stock-based compensation changed -41.6% from the comparable as-filed period.
Research & development changed -17.8% from the comparable as-filed period.
Gross profit changed +5.2% from the comparable as-filed period.
Revenue changed +5.2% from the comparable as-filed period.
Gross margin changed -0 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.